Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP785039.RAne-c93VhjknazF0SUj-QHX6s7-R0_FV0NHsdSFwOhC0130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP785039.RAne-c93VhjknazF0SUj-QHX6s7-R0_FV0NHsdSFwOhC0130_assertion type Assertion NP785039.RAne-c93VhjknazF0SUj-QHX6s7-R0_FV0NHsdSFwOhC0130_head.
- NP785039.RAne-c93VhjknazF0SUj-QHX6s7-R0_FV0NHsdSFwOhC0130_assertion description "[When we used the median expression levels of the NER proteins in the controls as cutoff values, we found that a significantly increased risk of SCCHN was associated with low expression of XPA [odds ratio (OR), 2.99; 95% confidence interval (CI), 1.22-7.47], XPC (OR, 2.46; 95% CI, 1.04-5.87), XPD (OR, 3.02; 95% CI, 1.18-7.76), and XPF (OR, 5.29; 95% CI, 2.01-13.9), but not ERCC1 and XPG, after adjustment for age, sex, ethnicity, smoking, alcohol use, and sample storage time.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP785039.RAne-c93VhjknazF0SUj-QHX6s7-R0_FV0NHsdSFwOhC0130_provenance.
- NP785039.RAne-c93VhjknazF0SUj-QHX6s7-R0_FV0NHsdSFwOhC0130_assertion evidence source_evidence_literature NP785039.RAne-c93VhjknazF0SUj-QHX6s7-R0_FV0NHsdSFwOhC0130_provenance.
- NP785039.RAne-c93VhjknazF0SUj-QHX6s7-R0_FV0NHsdSFwOhC0130_assertion SIO_000772 16103444 NP785039.RAne-c93VhjknazF0SUj-QHX6s7-R0_FV0NHsdSFwOhC0130_provenance.
- NP785039.RAne-c93VhjknazF0SUj-QHX6s7-R0_FV0NHsdSFwOhC0130_assertion wasDerivedFrom befree-20140225 NP785039.RAne-c93VhjknazF0SUj-QHX6s7-R0_FV0NHsdSFwOhC0130_provenance.
- NP785039.RAne-c93VhjknazF0SUj-QHX6s7-R0_FV0NHsdSFwOhC0130_assertion wasGeneratedBy ECO_0000203 NP785039.RAne-c93VhjknazF0SUj-QHX6s7-R0_FV0NHsdSFwOhC0130_provenance.